Kolexia
Flaujac Claire Pharmacien
Flaujac Claire
Pharmacien
Centre hospitalier de Versailles
Le Chesnay, France
79 Activités
238 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Thrombose Hémorragie COVID-19 Thrombopénie Fibrose Maladies de von Willebrand Cirrhose du foie Maladie grave

Collaborateurs

Voir plus
Ternisien Catherine
Ternisien Catherine
Hôpital Hôtel-Dieu Nantes, Nantes, France
Jeanpierre-Tomolillo Emmanuelle
Jeanpierre-Tomolillo Emmanuelle
Hôpital Albert Calmette, Lille, France
Eschwege Valerie
Eschwege Valerie
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Poncelin De Raucourt Emmanuelle
Poncelin De Raucourt Emmanuelle
Centre hospitalier de Versailles, Le Chesnay, France

Industries

Voir plus
LFB
4 collaboration(s)
Dernière en 2023
Sobi
3 collaboration(s)
Dernière en 2023
DIAGNOSTICA STAGO
3 collaboration(s)
Dernière en 2023
Bayer
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Commercial human frozen plasmas for local, cross-site and long-term comparability of coagulation analysers.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis   27 novembre 2023
Algorithmes décisionnels de l’allongement du temps de céphaline avec activateur (TCA)
La Presse Médicale Formation   01 août 2023
Factors Influencing anti-Xa assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin.
Thrombosis and haemostasis   15 juin 2023
A focus on dominant negative variants in a series of 170 heterozygous FXI-deficient patients.
Haemophilia : the official journal of the World Federation of Hemophilia   30 mai 2023
Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study.
Journal of thrombosis and haemostasis : JTH   11 mai 2023
Incidence of deep venous thrombosis in COVID-19 critically ill patients treated with intermediate-dose of heparin for thromboprophylaxis: The COVIDOP-DVT observational study.
Vascular   03 avril 2023
Emicizumab assays evaluations with four different reagents in severe haemophilia A patients: Concentration from baseline to maintenance therapy.
Haemophilia : the official journal of the World Federation of Hemophilia   29 novembre 2022
121.1 Pregnancy in women with factor XI deficiency (<60 UI/dl) and use of neuraxial analgesia: Real life data in a French cohort of 314 pregnancies
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
92.1 Evaluation of four different reagents on the coagulation analyzers STAR MAX® and ATELLICA® COAG 360 for Emicizumab concentration measurement in severe hemophilia A patients
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Factors influencing anti-Xa assays in different groups of critically ill and non-critically ill patients receiving unfractionated heparin: A multicenter prospective study
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022